p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Link
http://www.nature.com/articles/cdd201181.pdf
Reference126 articles.
1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305–316.
2. Schmale H, Bambergeric C . A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997; 15: 1363–1366.
3. Trink B, Okami K, Wu L, Spiuranpong V, Jen J, Sidransky D . A new human p53 homolog. Nat Med 1998; 4: 747–748.
4. Senoo M, Seiki N, Ohira M, Sugano S, Watanabe M, Tachibana M et al. A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Commun 1998; 248: 603–607.
5. Senoo M, Seiki N, Ohira M, Sugano S, Watanabe M, Tachibana M et al. A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Commun 1998; 248: 603–607.
Cited by 191 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RIPK4 driven by TP53 mutations promotes resistance to redox stress of CRC by phosphorylating MTHFD1;2024-08-06
2. How MicroRNAs Command the Battle against Cancer;International Journal of Molecular Sciences;2024-05-28
3. Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer;Journal of Personalized Medicine;2024-04-30
4. Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer;Nature Communications;2024-03-20
5. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α;Cell Death & Differentiation;2024-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3